Predicting anthracycline benefit: have we made any progress?-Reference-Cited by-同舟云学术

Predicting anthracycline benefit: have we made any progress?

Published:2009-11 Issue:6 Volume:21 Page:507-515
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:

Author:

Moretti Erica,Oakman Catherine,Di Leo Angelo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference52 articles.

1. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 8th ed;DeVita,2008

2. BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II;Treszezamsky;Cancer Res,2007

3. Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations;Sauter;J Clin Onc,2009

4. A, Hammond M, Schwartz, et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.;J Clin Onc,2007

5. ErbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer;Paik;J Natl Cancer Inst,1998

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyrophen Isolated from the Endophytic Fungus Aspergillus fumigatus Strain KARSV04 Synergizes the Effect of Doxorubicin in Killing MCF7 but not T47D Cells;Turkish Journal of Pharmaceutical Sciences;2020-06-01

2. Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity;Molecular Pharmacology;2015-06-22

3. Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency;Cancer Cell;2012-04

4. Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells;PLoS ONE;2011-12-02

5. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer;Breast Cancer Research;2011-12